AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
9min chapter
274: Covid’s latest surge, Alnylam at the FDA, & the end of an era
The Readout Loud
Bluebird Bio Restructuring Announcement
This chapter discusses the recent restructuring announcement made by Bluebird Bio / 270 Bio, including the reduction in force and exit of their CEO. It highlights the challenges faced by Bluebird Bio and 270 Bio in the oncology field, along with the rapid advancements in gene therapies and genome editing.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode